Condensed Statements of Shareholders' Deficiency (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)			1,233,853
Beginning balance	$ (877,536)	$ (785,812)	$ (835,505)	$ (745,020)
Net loss	$ (21,739)	(19,781)	$ (63,770)	(60,573)
Ending balance (in shares)	1,233,853		1,233,853
Ending balance	$ (899,275)	$ (805,593)	$ (899,275)	$ (805,593)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Beginning balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Ending balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Ending balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	81,323	81,323	81,323	81,323
Ending balance	81,323	81,323	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(960,092)	(868,368)	(918,061)	(827,576)
Net loss	(21,739)	(19,781)	(63,770)	(60,573)
Ending balance	$ (981,831)	$ (888,149)	$ (981,831)	$ (888,149)